InnoCare Urologics

What InnoCare Urologics does

InnoCare Urologics, LLC is a Miami-based medical-device company and wholly owned subsidiary of InnoCare, Inc. (doing business in Florida as InnoCare Safety Catheters, Inc.) that designs, manufactures, and commercializes the Egress Safety Catheter, a 16 Fr, 2-way silicone Foley catheter integrating the proprietary Egress AutoValve — a secondary deflation mechanism that automatically deflates the retention balloon when an external pulling force above a predetermined threshold is applied. The device is the first FDA-cleared product under a new product classification code (SCT) for Foley Catheters and Accessories with Additional Safety Features, and is offered in two SKUs (ESC1610ST straight tip and ESC1610CT Coudé tip), each with a 10 mL balloon. It addresses the approximately 700,000-plus U.S. catheter pullout events per year and an estimated $4.5 billion in annual downstream injury-treatment costs, with the highest-acuity use cases in ICU, post-surgical, and dementia/delirium patient populations.

The company operates a contact-based enterprise field-sales motion targeting hospitals, intensive care units, and other healthcare facilities, with a clinical endorsement in place from Dr. Bruce Gardner of Sanford Health. Marketing is primarily website-driven, supplemented by industry-ecosystem visibility through the 2025 AUA Innovation Nexus Showcase (one of only 14 companies selected) and the BioFlorida BioPitch Award. Distribution is direct to healthcare facilities with no publicly disclosed distributor network, and pricing is not publicly disclosed, instead negotiated inbound through the website or via [email protected]. Legal entity is a Florida LLC governed by Florida law, with 1–10 employees and no disclosed institutional funding rounds.

Name

InnoCare Urologics

Legal name

InnoCare Urologics, LLC

Website

https://innocareurologics.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

InnoCare Urologics is a Miami-based medical-device company that designs the Egress Safety Catheter, an FDA-cleared Foley catheter with an integrated AutoValve that auto-deflates the retention balloon when pulled, targeting hospitals, ICUs, and high-risk patients including those with dementia or delirium.

Ownership category

akta.pro rank

Product category

Urology Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Urinary Catheters & Drainage (Intermittent/Foley Catheters, Bags, Securement) (HLAHALAI)

akta.pro secondary industry

Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies) (HSABAKAH)

Keywords

• Urinary catheters
• Foley catheters
• Urology medical devices
• Patient safety catheters
• Indwelling catheter systems

Headquarters

HQ city

Miami

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Marketing or Sales, Personnel, Supply Chain

Revenue model

1. Medical Device Sales: Sale of the Egress Safety Catheter and Egress AutoValve products to healthcare facilities. The device is available in Straight (ESC1610ST) and Coude tip (ESC1610CT) configurations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

InnoCare Urologics designs, manufactures, and sells the Egress Safety Catheter — a 16 Fr, 2-way silicone Foley catheter with an integrated Egress AutoValve that automatically deflates the retention balloon when a patient pulls the catheter while it is still inflated, preventing urethral and bladder injuries. The product is offered in Straight (ESC1610ST) and Coudé (ESC1610CT) tip configurations and is sold to hospitals, ICUs, and other healthcare facilities in the United States.

Product overview

InnoCare Urologics offers a single unified medical device product — the Egress Safety Catheter with integrated Egress AutoValve technology. The portfolio consists of the flagship Egress Safety Catheter available in two variants: the ESC1610ST (Straight Tip) and ESC1610CT (Coudé Tip), both 16 Fr, 2-way silicone Foley catheters with 10 mL balloons. The core innovation is the Egress AutoValve, a secondary deflation mechanism integrated into the catheter that automatically deflates the balloon if the catheter is pulled while still inflated, distinguishing it from standard Foley catheters.

Differentiator

Problem solved

Functional benefit

Products and services

• Egress Safety Catheter 16 Fr, 2-way silicone Foley catheter with an integrated Egress AutoValve secondary deflation mechanism that automatically deflates the retention balloon when external pulling force is applied, preventing urethral and bladder injuries in adult patients. Available in Straight (ESC1610ST) and Coudé (ESC1610CT) tip configurations, both with 10 mL balloons. Sold to hospitals, ICUs, and healthcare facilities for use in adult patients, including home use under professional guidance.

Quantifiable outcome

• Prevents injuries from over 700,000 catheter pullout events per year
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Coloplast: Coloplast is a major manufacturer of urological and continence care products including Foley and intermittent catheters. Comparable as an established player in urinary catheterization targeting hospitals and home care patients.
• ConvaTec: ConvaTec produces continence and urological care devices including catheters for hospital and home use. Comparable as a broader continence-care incumbent that could develop or acquire a competing safety catheter.
• Becton Dickinson (BD): BD is one of the largest manufacturers of Foley catheters (BARDEX portfolio) and urological care products sold to hospitals globally. Directly comparable as the incumbent leader in the same product category that InnoCare is attempting to upgrade with safety features.
• B. Braun Medical: B. Braun manufactures a portfolio of urinary catheters and urological accessories sold to hospitals and clinical settings. Comparable as an established medical device manufacturer with overlapping hospital catheter offerings.
• Teleflex: Teleflex produces a broad urological catheter portfolio including Foley catheters sold to hospitals and clinicians. Comparable as a large incumbent in the same product category with established hospital sales coverage.

Others

• Medline Industries: Medline is one of the largest medical supply manufacturers and distributors, with a substantial urological product portfolio sold to hospitals. Comparable as both a potential distribution partner and competitor given its broad catheter manufacturing footprint.
• Cardinal Health: Cardinal Health is a major medical product distributor that supplies catheters and urological devices to hospitals through its medical segment. Comparable as a critical channel partner that could distribute or compete with InnoCare's product in hospital systems.

Direct peers

• Wellspect Healthcare: Wellspect, a Mölnlycke Health Care company, manufactures intermittent and Foley catheters with focus on urological care. Comparable as a specialist catheter manufacturer serving similar hospital and home care urological patients.
• Hollister Incorporated: Hollister manufactures continence care products including Foley and intermittent catheters serving both hospital and home care markets. Comparable as a direct competitor targeting the same urological patient populations and care settings.

Emerging players

• Cure Medical: Cure Medical manufactures intermittent and Foley catheters targeting both hospital and home urological care markets. Comparable as a smaller specialist catheter manufacturer competing for similar patient segments in urological care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/innocare-urologics

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InnoCare Urologics